Merck to Hold Second-Quarter 2014 Sales and Earnings Conference Call on July 29
June 23 2014 - 5:00PM
Business Wire
Merck (NYSE:MRK), known as MSD outside the United States and
Canada, will hold its second-quarter 2014 sales and earnings
conference call with institutional investors and analysts at 8:00
a.m. EDT on Tuesday, July 29. During the call, company executives
will provide an overview of Merck’s performance for the
quarter.
Investors, journalists and the general public may access a live
audio webcast of the call on Merck’s website at
http://www.merck.com/investors/events-and-presentations/home.html.
Software needed to listen to the webcast is available on Merck’s
website and should be downloaded prior to the beginning of the
webcast. A replay of the webcast will be available at approximately
11:00 a.m. EDT on July 29 and will remain on the website for 12
months. The quarter's sales and earnings news release and
supplemental financial disclosures also will be available in the
Newsroom and Investor sections of the company's website at
www.merck.com.
Institutional investors and analysts can participate in the call
by dialing (706) 758-9927 or (877) 381-5782 and using ID code
number 62998996. Members of the media are invited to monitor the
call by dialing (706) 758-9928 or (800) 399-7917 and using ID code
number 62998996. Journalists who wish to ask questions are
requested to contact a member of Merck's Media Relations team at
the conclusion of the call.
About Merck
Today's Merck is a global healthcare leader working to help the
world be well. Merck is known as MSD outside the United States and
Canada. Through our prescription medicines, vaccines, biologic
therapies, and consumer care and animal health products, we work
with customers and operate in more than 140 countries to deliver
innovative health solutions. We also demonstrate our commitment to
increasing access to healthcare through far-reaching policies,
programs and partnerships. For more information, visit
www.merck.com and connect with us on Twitter, Facebook and
YouTube.
Merck Forward-Looking Statement
This news release includes “forward-looking statements” within
the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. These statements
are based upon the current beliefs and expectations of Merck’s
management and are subject to significant risks and uncertainties.
If underlying assumptions prove inaccurate or risks or
uncertainties materialize, actual results may differ materially
from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general
industry conditions and competition; general economic factors,
including interest rate and currency exchange rate fluctuations;
the impact of pharmaceutical industry regulation and health care
legislation in the United States and internationally; global trends
toward health care cost containment; technological advances, new
products and patents attained by competitors; challenges inherent
in new product development, including obtaining regulatory
approval; Merck’s ability to accurately predict future market
conditions; manufacturing difficulties or delays; financial
instability of international economies and sovereign risk;
dependence on the effectiveness of Merck’s patents and other
protections for innovative products; and the exposure to
litigation, including patent litigation, and/or regulatory
actions.
Merck undertakes no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future events or otherwise. Additional factors that could cause
results to differ materially from those described in the
forward-looking statements can be found in Merck’s 2013 Annual
Report on Form 10-K and the company’s other filings with the
Securities and Exchange Commission (SEC) available at the SEC’s
Internet site (www.sec.gov).
MerckMedia:Lainie Keller, 908-423-4187Steven Cragle,
908-423-3461orInvestor:Justin Holko, 908-423-5088Joe Romanelli,
908-423-5185
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024